IPCA LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of IPCA LABORATORIES have increased by 7.03% YoY .
The Earnings Per Share (EPS) of IPCA LABORATORIES has increased by 16.09 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
IPCA LABORATORIES Last 5 Annual Financial Results
[BOM: 524494|NSE : IPCALAB]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹6,204 Cr | ₹5,797 Cr | ₹5,395 Cr | ₹4,619 Cr | ₹3,746 Cr |
| Expenses | ₹5,301 Cr | ₹4,539 Cr | ₹3,914 Cr | ₹3,729 Cr | ₹3,067 Cr |
| Operating Profit (Excl OI) | ₹903 Cr | ₹1,258 Cr | ₹1,481 Cr | ₹890 Cr | ₹678 Cr |
| Other Income | ₹152 Cr | ₹122 Cr | ₹129 Cr | ₹87 Cr | ₹75 Cr |
| Interest | ₹48 Cr | ₹11 Cr | ₹12 Cr | ₹20 Cr | ₹22 Cr |
| Depreciation | ₹262 Cr | ₹232 Cr | ₹209 Cr | ₹211 Cr | ₹182 Cr |
| Profit Before Tax | ₹745 Cr | ₹1,136 Cr | ₹1,389 Cr | ₹739 Cr | ₹546 Cr |
| Profit After Tax | ₹492 Cr | ₹911 Cr | ₹1,149 Cr | ₹604 Cr | ₹442 Cr |
| Consolidated Net Profit | ₹471 Cr | ₹884 Cr | ₹1,140 Cr | ₹606 Cr | ₹446 Cr |
| Earnings Per Share (Rs) | ₹21.57 | ₹18.58 | ₹34.85 | ₹89.87 | ₹47.99 |
| PAT Margin (%) | 6.87 | 7.88 | 15.63 | 21.20 | 12.98 |
| ROE(%) | 8.70 | 8.70 | 17.92 | 27.63 | 17.92 |
| ROCE(%) | 13.10 | 11.71 | 20.46 | 30.92 | 19.71 |
| Total Debt/Equity(x) | 0.22 | 0.25 | 0.14 | 0.05 | 0.13 |
Key Financials |
||
| Market Cap | : | ₹ 40,192.4 Cr |
| Revenue (TTM) | : | ₹ 8,533.4 Cr |
| Net Profit(TTM) | : | ₹ 670.0 Cr |
| EPS (TTM) | : | ₹ 26.4 |
| P/E (TTM) | : | 60.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| IPCA LABORATORIES | 1.2% | 0.7% | 41.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
| CIPLA | 1.7% | 0.5% | 23.7% |
| DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
| ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
| DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
| MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
| TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
| LUPIN | 4.1% | 5.1% | 71.7% |
IPCA LABORATORIES Revenues
[BOM: 524494|NSE : IPCALAB]
| Y-o-Y | 7.03 % |
| 5 Yr CAGR | 13.45 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹6,204 Cr | 7.03 | |
| Mar2023 | ₹5,797 Cr | 7.45 | |
| Mar2022 | ₹5,395 Cr | 16.80 | |
| Mar2021 | ₹4,619 Cr | 23.32 | |
| Mar2020 | ₹3,746 Cr | - | |
IPCA LABORATORIES Operating Profit
[BOM: 524494|NSE : IPCALAB]
| Y-o-Y | -28.18 % |
| 5 Yr CAGR | 7.42 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹903 Cr | -28.18 | |
| Mar2023 | ₹1,258 Cr | -15.10 | |
| Mar2022 | ₹1,481 Cr | 66.34 | |
| Mar2021 | ₹890 Cr | 31.29 | |
| Mar2020 | ₹678 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -32.90 % |
| 5 Yr CAGR | -5.31 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 14.56% | -32.90 | |
| Mar2023 | 21.7% | -20.98 | |
| Mar2022 | 27.46% | 42.43 | |
| Mar2021 | 19.28% | 6.46 | |
| Mar2020 | 18.11% | - | |
IPCA LABORATORIES Profit After Tax
[BOM: 524494|NSE : IPCALAB]
| Y-o-Y | -46.69 % |
| 5 Yr CAGR | 1.41 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹471 Cr | -46.69 | |
| Mar2023 | ₹884 Cr | -22.45 | |
| Mar2022 | ₹1,140 Cr | 88.02 | |
| Mar2021 | ₹606 Cr | 36.07 | |
| Mar2020 | ₹446 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -12.82 % |
| 5 Yr CAGR | -14.71 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 6.87 % | -12.82 | |
| Mar2023 | 7.88 % | -49.58 | |
| Mar2022 | 15.63 % | -26.27 | |
| Mar2021 | 21.2 % | 63.33 | |
| Mar2020 | 12.98 % | - | |
IPCA LABORATORIES Earnings Per Share (EPS)
[BOM: 524494|NSE : IPCALAB]
| Y-o-Y | 16.09 % |
| 5 Yr CAGR | -18.12 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹22 | 16.09 | |
| Mar2023 | ₹19 | -46.69 | |
| Mar2022 | ₹35 | -61.22 | |
| Mar2021 | ₹90 | 87.27 | |
| Mar2020 | ₹48 | - | |
IPCA LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524494|NSE : IPCALAB]
| Y-o-Y | 11.87 % |
| 5 Yr CAGR | -9.71 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 13.1% | 11.87 | |
| Mar2023 | 11.71% | -42.77 | |
| Mar2022 | 20.46% | -33.83 | |
| Mar2021 | 30.92% | 56.87 | |
| Mar2020 | 19.71% | - | |
IPCA LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹1,584.3 |
| Current MarketCap | : | ₹ 40,192.4 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 1.2% |
0.7% |
41.7% |
| SENSEX | -5% |
0.6% |
9.2% |
IPCA LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 0.1% | 4% | 45% |
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE MIDSMALLCAP | -3.2% | 4.4% | 29.5% |
| S&P BSE MID CAP | -3.2% | 3.6% | 27.7% |
| S&P BSE 150 MIDCAP | -3.4% | 3.4% | 26.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY PHARMA | 1.6% | 3.4% | 39.1% |
| NIFTY HEALTHCARE | 0.9% | 4.6% | 40.8% |
| NIFTY MID SMALL400 | -3.2% | 4.3% | 26% |
| NIFTY MIDCAP150 | -3.2% | 3.9% | 24.9% |
| NIFTY500 MULTICAP 50:25:25 | -4.1% | 2.4% | 19.8% |
You may also like the below Video Courses
FAQ about IPCA LABORATORIES Financials
How the annual revenues of IPCA LABORATORIES have changed ?
The Revenues of IPCA LABORATORIES have increased by 7.03% YoY .
How the Earnings per Share (EPS) of IPCA LABORATORIES have changed?
The Earnings Per Share (EPS) of IPCA LABORATORIES has increased by 16.09 % YoY .
Check out Intrinsic Value of Peers of IPCA LABORATORIES
Compare Stock Analytics of Peers of IPCA LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
